Circ-RPPH1 knockdown retarded cell malignant phenotypes and glycolysis via miR-328-3p/HMGA2 axis in BC, providing a potential therapeutic target for BC treatment.
Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA2.